Literature DB >> 7537213

Interleukin-3 signals through multiple isoforms of Stat5.

M Azam1, H Erdjument-Bromage, B L Kreider, M Xia, F Quelle, R Basu, C Saris, P Tempst, J N Ihle, C Schindler.   

Abstract

The interleukin (IL)-3 family of cytokines mediates its numerous effects on myeloid growth and maturation by binding a family of related receptors. It has been shown recently that IL-3 induces the activation of two distinct cytoplasmic signal transducing factors (STFs) that are likely to mediate the induction of immediate early genes. In immature myeloid cells, IL-3 activates STF-IL-3a, which comprises two tyrosine-phosphorylated DNA binding proteins of 77 and 80 kDa. In mature myeloid cells, IL-3 and granulocyte-macrophage colony-stimulating factor activate STF-IL-3b, which consists of a 94 and 96 kDa tyrosine-phosphorylated DNA binding protein. Peptide sequence data obtained from the purified 77 and 80 kDa proteins (p77 and p80) indicate that they are closely related but are encoded by distinct genes. Both peptide and nucleotide sequence data demonstrate that these two proteins are the murine homologs of ovine mammary gland factor (MGF)/Stat5. The peptide data also indicate that p77 and p80 are phosphorylated on tyrosine 699, a position analogous to the tyrosine that is phosphorylated in Stat1 and Stat2 in response to interferon. Additionally, antiserum raised against bacterially expressed p77/p80 recognizes the 94 and 96 kDa protein components of STF-IL-3b, suggesting that these may be additional isoforms of Stat5. These studies indicate that the IL-3 family of ligands is able to activate multiple isoforms of the signal transducing protein Stat5.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537213      PMCID: PMC398225          DOI: 10.1002/j.1460-2075.1995.tb07126.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  53 in total

1.  Internal sequence analysis of proteins separated on polyacrylamide gels at the submicrogram level: improved methods, applications and gene cloning strategies.

Authors:  P Tempst; A J Link; L R Riviere; M Fleming; C Elicone
Journal:  Electrophoresis       Date:  1990-07       Impact factor: 3.535

2.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

3.  The trk oncogene abrogates growth factor requirements and transforms hematopoietic cells.

Authors:  S Katzav; D Martin-Zanca; M Barbacid; A M Hedge; R Isfort; J N Ihle
Journal:  Oncogene       Date:  1989-09       Impact factor: 9.867

4.  Isolation and characterization of a cloned growth factor dependent macrophage cell line, BAC1.2F5.

Authors:  C Morgan; J W Pollard; E R Stanley
Journal:  J Cell Physiol       Date:  1987-03       Impact factor: 6.384

5.  Interleukin 5 and interleukin 3 induce serine and tyrosine phosphorylations of several cellular proteins in an interleukin 5-dependent cell line.

Authors:  Y Murata; N Yamaguchi; Y Hitoshi; A Tominaga; K Takatsu
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

6.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis.

Authors:  O Miura; A D'Andrea; D Kabat; J N Ihle
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

8.  Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons.

Authors:  D J Lew; T Decker; I Strehlow; J E Darnell
Journal:  Mol Cell Biol       Date:  1991-01       Impact factor: 4.272

Review 9.  Origins and properties of hematopoietic growth factor-dependent cell lines.

Authors:  J N Ihle; D Askew
Journal:  Int J Cell Cloning       Date:  1989-03

10.  Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D.

Authors:  G Migliaccio; A R Migliaccio; B L Kreider; G Rovera; J W Adamson
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

View more
  66 in total

1.  A Stat3-interacting protein (StIP1) regulates cytokine signal transduction.

Authors:  R G Collum; S Brutsaert; G Lee; C Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

2.  Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.

Authors:  M Kieslinger; I Woldman; R Moriggl; J Hofmann; J C Marine; J N Ihle; H Beug; T Decker
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

3.  DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.

Authors:  E Soldaini; S John; S Moro; J Bollenbacher; U Schindler; W J Leonard
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 4.  Signal transducer and activator of transcription (STAT) signalling and T-cell lymphomas.

Authors:  Tracey J Mitchell; Susan John
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

5.  Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response.

Authors:  F W Quelle; D Wang; T Nosaka; W E Thierfelder; D Stravopodis; Y Weinstein; J N Ihle
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

6.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression.

Authors:  G B Udy; R P Towers; R G Snell; R J Wilkins; S H Park; P A Ram; D J Waxman; H W Davey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

7.  An N-terminal splice variant of human Stat5a that interacts with different transcription factors is the dominant form expressed in invasive ductal carcinoma.

Authors:  Dunyong Tan; KuanHui E Chen; Changhui Deng; Peizhi Tang; Jianjun Huang; Trina Mansour; Richard A Luben; Ameae M Walker
Journal:  Cancer Lett       Date:  2013-12-30       Impact factor: 8.679

8.  IL-3 induces basophil expansion in vivo by directing granulocyte-monocyte progenitors to differentiate into basophil lineage-restricted progenitors in the bone marrow and by increasing the number of basophil/mast cell progenitors in the spleen.

Authors:  Keitaro Ohmori; Yuchun Luo; Yi Jia; Jun Nishida; Zhengqi Wang; Kevin D Bunting; Demin Wang; Hua Huang
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

9.  Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.

Authors:  R Moriggl; V Gouilleux-Gruart; R Jähne; S Berchtold; C Gartmann; X Liu; L Hennighausen; A Sotiropoulos; B Groner; F Gouilleux
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Human interleukin-3 (IL-3) induces disulfide-linked IL-3 receptor alpha- and beta-chain heterodimerization, which is required for receptor activation but not high-affinity binding.

Authors:  F C Stomski; Q Sun; C J Bagley; J Woodcock; G Goodall; R K Andrews; M C Berndt; A F Lopez
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.